Atlas Trials

Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Clinical trial NCT00251550 · COMPLETED

Trial details

NCT number
NCT00251550
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Pleural Mesotherioma
Start date
2005-10-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.